KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Ionis Pharmaceuticals (IONS) over the last 13 years, with Q3 2025 value amounting to $158.0 million.

  • Ionis Pharmaceuticals' Other Working Capital Changes rose 57911.02% to $158.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.2 million, marking a year-over-year increase of 15917.86%. This contributed to the annual value of -$156.8 million for FY2024, which is 56447.0% down from last year.
  • Ionis Pharmaceuticals' Other Working Capital Changes amounted to $158.0 million in Q3 2025, which was up 57911.02% from -$20.8 million recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Other Working Capital Changes ranged from a high of $158.0 million in Q3 2025 and a low of -$62.7 million during Q2 2024
  • Over the past 5 years, Ionis Pharmaceuticals' median Other Working Capital Changes value was -$16.0 million (recorded in 2022), while the average stood at -$8.1 million.
  • Per our database at Business Quant, Ionis Pharmaceuticals' Other Working Capital Changes crashed by 47829.9% in 2021 and then soared by 81727.92% in 2023.
  • Over the past 5 years, Ionis Pharmaceuticals' Other Working Capital Changes (Quarter) stood at -$11.2 million in 2021, then plummeted by 41.03% to -$15.8 million in 2022, then tumbled by 165.38% to -$42.0 million in 2023, then skyrocketed by 65.94% to -$14.3 million in 2024, then skyrocketed by 1204.66% to $158.0 million in 2025.
  • Its last three reported values are $158.0 million in Q3 2025, -$20.8 million for Q2 2025, and -$13.7 million during Q1 2025.